About EnsoData

EnsoData’s waveform AI platform provides clinicians, device manufacturers, and payors with AI-powered software solutions to identify, diagnose, and treatment sleep disordered patients. EnsoData’s first product, EnsoSleep, automates event detection and analysis of sleep studies, reducing the time required to score studies and providing clinicians with more time to focus on patient care.

Established:

2015

Leaders:

Chris Fernandez | CEO & Co-Founder
Sam Rusk | President & Co-Founder
Nick Glattard | CTO & Co-Founder
Brock Hensen |COO

LinkedIn Facebook Twitter Website

Work for EnsoData

View Open Positions

In the News

Leading Healthcare Artificial Intelligence Company Raises $20m Series A Extension Cision PRWeb

EnsoData’s additional funding, coupled with new partnerships and an executive hire, fuels rapid growth and accelerated delivery of its validated AI solution for sleep medicine

Read More
EnsoData Named to Inc. Magazine’s Annual List of Best Workplaces for the Second Year in a Row Yahoo Finance

For the second year in a row, EnsoData, the leading AI healthcare company helping clinicians uncover disease while patients sleep, has been named to Inc. magazine's annual Best Workplaces list.

Read More
Inspire Medical Systems Invests in AI Startup EnsoData HIT Consultant

Inspire Medical Systems has announced its investment in EnsoData, an artificial intelligence (AI) healthcare company helping clinicians uncover disease while patients sleep.

Read More
1 2

We’d love to hear from you.

Have an idea? Building a company? Seeking to partner with our portfolio companies? Please reach out, we’d love to hear from you.

Get In Touch